Description
BAVENCIO (avelumab) is a prescription monoclonal antibody used in immunotherapy to treat certain cancers by blocking PD-L1, helping the immune system fight tumor cells. It's given as an intravenous infusion at a strength of 20 mg/mL. This information was generated using AI and is provided for informational and research purposes only.
Resources
| Name | Format | Description | Link |
|---|---|---|---|
| Avelumab | HTML | Access the FDA dataset for Avelumab — ANDA 761049 submitted by Mylan Institutional LLC | Open resource |